Why Edwards Lifesciences (EW) Is Up 7.6% After Positive Long-Term Data for SAPIEN Valve Platform

In recent days, Edwards Lifesciences announced positive long-term clinical trial results for its SAPIEN TAVR technology and ...
Security

GE Agrees to Buy SPX's Fire-and-Security Unit Edwards Systems for $1.4 Billion

CHARLOTTE, N.C. (AP) -- General Electric Co. will buy SPX Corp.'s Edwards Systems Technology fire-and-security unit for nearly $1.4 billion in cash, both companies said Monday. The sale, which is ...
Barchart on MSN

Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish?

With a market cap of $48.4 billion, Edwards Lifesciences Corporation (EW) is a global medical technology company specializing ...
Medical Device Network on MSN

Edwards solidifies TAVR dominance in long-term trial readout

The respective readouts demonstrated TAVR’s comparable performance to surgical aortic valve replacement treatment.
Business Wire

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...